Dr. Dhruva is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4150 Clement St
Bldg 203
San Francisco, CA 94121Phone+1 415-221-4810
Education & Training
- University of California Davis HealthFellowship, Cardiovascular Disease, 2012 - 2015
- University of California (San Francisco)Residency, Internal Medicine, 2009 - 2012
- University of California San Francisco School of MedicineClass of 2009
Certifications & Licensure
- CA State Medical License 2010 - 2026
- CT State Medical License 2015 - 2018
- American Board of Internal Medicine Cardiovascular Disease
Clinical Trials
- Post-Market Surveillance With a Novel mHealth Platform Start of enrollment: 2018 Jan 26
Publications & Presentations
PubMed
- 51 citationsRevisiting Essure — Toward Safe and Effective SterilizationSanket S. Dhruva, Joseph S. Ross, Aileen M. Gariepy
The New England Journal of Medicine. 2015-10-07 - 20 citationsThe FDA Unapproved Drugs Initiative: An Observational Study of the Consequences for Drug Prices and Shortages in the United StatesRavi Gupta, Sanket S. Dhruva, Erin R. Fox, Joseph S. Ross
Journal of Managed Care & Specialty Pharmacy. 2017-09-25 - 60 citationsUse of Mechanical Circulatory Support Devices Among Patients With Acute Myocardial Infarction Complicated by Cardiogenic Shock.Sanket S. Dhruva, Joseph S. Ross, Bobak J. Mortazavi, Nathan C. Hurley, Harlan M. Krumholz
JAMA Network Open. 2021-02-01
Journal Articles
- Trends in Within-Class Changes in US Average Wholesale Prices for Brand-Name Medications for Common Conditions from 2015 to 2020Sanket Dhruva, MD, JAMA Network Open
- Intravascular Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump for Cardiogenic Shock—ReplySanket S Dhruva, Nihar R Desai, JAMA
- Trends in Use of Transcatheter Aortic Valve Replacement by AgeRita F Redberg, Art Sedrakyan, Sanket S Dhruva, JAMA
Authored Content
- Intravascular Microaxial Left Ventricular Assist Device vs Intra-Aortic Balloon Pump for Cardiogenic Shock—ReplyJuly 2020
Press Mentions
- Blood Tests for Cancer Detection Aren’t yet Ready for Prime TimeJune 11th, 2024
- Manufacturer Payments Tied to Use of More Expensive Medical DevicesApril 24th, 2024
- Do All Those Postmarket Device Modifications Add up to Patient Harm?April 12th, 2023
- Join now to see all
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: